BioCentury
ARTICLE | Clinical News

Amoxicillin: Phase III start

September 27, 2004 7:00 AM UTC

AVNC will begin next month a double-blind, U.S. Phase III trial in 500 patients comparing once-daily 775 mg Amoxicillin Pulsys for 7 days to 250 mg of penicillin dosed 4 times a day for 10 days. ...